AURXOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Nuo Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.26−0.04 (-3.08%)
Close on Oct 19, 2026
- Market cap
- $60.99M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$1.24 (−49.57%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Nuo Therapeutics, Inc. grew revenue 166.6% to $5.20M over the twelve months to Jun 30, 2026. Free cash flow was -$2.45M.
Revenue
$5.20M
+166.6% vs. a year earlier
Operating income
-$1.73M
TTM Q2 2026
Free cash flow
-$2.45M
TTM Q2 2026
EPS, diluted
-$0.04
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $60.99M
- P/E ratio
- –
- Price to sales
- 11.73
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -4.01%
Fundamentals
- Revenue
- $5.20M
- Net income
- -$2.01M
- EPS, diluted
- -$0.04
- Free cash flow
- -$2.45M
- Book value per share
- -$0.03
- Diluted shares
- 48M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$5.20M+166.6% YoY
Gross profit
$3.33M+124.8% YoY
Operating income
-$1.73M
Net income
-$2.01M
EPS, diluted
-$0.04
Free cash flow
-$2.45M
Reported periodTrailing twelve months